Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Cancer Therapy
Quality of life considerations impact choice of cancer treatment
November 24th, 2005
Quality of life considerations impact the choice between adjuvant chemotherapy and ovarian suppression for cancer treatment. According to investigators from the United States, "Recent clinical trials suggest that adjuvant ovarian suppression may be an equally effective and less toxic alternative to systemic chemotherapy in premenopausal women with hormone-responsive breast cancer." E. B. Elkin and colleagues "used a decision-analytic framework to evaluate tradeoffs between efficacy and quality of life in the choice between these treatments." The authors "used a Markov state-transition model to simulate clinical practice in a cohort of 40-year-old...
Source: Women's Health Weekly (2005-11-24)
|
